Triheptanoin

Triheptanoin (Propane-1,2,3-triyl triheptanoate) is a synthetic medium-chain triglyceride (MCT) consisting of three odd-chain 7-carbon (heptanoate) fatty acids on a glycerol backbone. Triheptanoin can be used for the research of inherited metabolic disorders[1].

Product Specifications

CAS Number

[620-67-7]

Product Name Alternative

UX007

UNSPSC

12352211

Hazard Statement

H315, H372, H411

Target

Biochemical Assay Reagents

Type

Reference compound

Related Pathways

Others

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/triheptanoin.html

Purity

99.94

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

CCCCCCC(OCC(OC(CCCCCC)=O)COC(CCCCCC)=O)=O

Molecular Formula

C24H44O6

Molecular Weight

428.61

Precautions

H315, H372, H411

References & Citations

[1]Matt Shirley. Triheptanoin: First Approval. Drugs. 2020 Oct;80 (15) :1595-1600.|[2]A J Yeo, et al. An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T) . Mol Metab. 2021 Dec;54:101354. |[3]Kah Ni Tan, et al. Triheptanoin protects against status epilepticus-induced hippocampal mitochondrial dysfunctions, oxidative stress and neuronal degeneration. J Neurochem. 2018 Feb;144 (4) :431-442.